Objective : Spinal deformity surgery has the potential risk of massive blood loss. To reduce surgical bleeding, the use of tranexamic acid (TXA) became popular in spinal surgery, recently. The purpose of this study was to determine the effectiveness of intraoperative TXA use to reduce surgical bleeding and transfusion requirements in spinal deformity surgery. Methods : A total of 132 consecutive patients undergoing multi-level posterior spinal segmental instrumented fusion (≥5 levels) were analyzed retrospectively. Primary outcome measures included intraoperative estimated blood loss (EBL), transfusion amount and rate of transfusion. Secondary outcome measures included postoperative transfusion amount, rate of transfusion, and complications associated with TXA or allogeneic blood transfusions. Results : The number of patients was 89 in TXA group and 43 in non-TXA group. There were no significant differences in demographic or surgical traits between the groups except hypertension. The EBL was significantly lower in TXA group than non-TXA group (841 vs. 1336 mL, p=0.002). TXA group also showed less intra-operative and postoperative transfusion requirements (544 vs. 812 mL, p=0.012; 193 vs. 359 mL, p=0.034). Based on multiple regression analysis, TXA use could reduce surgical bleeding by 371 mL (37 % of mean EBL). Complication rate was not different between the groups. Conclusion : TXA use can effectively reduce the amount of intra-operative bleeding and transfusion requirements in spinal deformity surgery. Future randomized controlled study could confirm the routine use of TXA in major spinal surgery.
INTRODUCTION
Spinal deformity surgery has the potential for massive blood loss 15, 19) . Especially during long level lumbar or thoracic instrumented fusion with or without osteotomy, blood loss may be substantial and transfusion is required in most cases 11, 12) . Extensive blood loss can lead to massive blood transfusions, pulmonary or cerebral edema, and shock. Allogeneic blood transfusions are associated with blood-borne disease transmission, hemolytic and non-hemolytic transfusion reactions, and transfusion-related cost 6, 21) . Moreover, there are not a few literatures reporting allogeneic blood transfusions were related to not only wound infection but also overall postoperative infections 9, 13) . Therefore, there have been many options in blood conservation strategies to reduce surgical bleeding and intraoperative allogeneic blood transfusions. Such options include patients positioning to avoid abdominal compression, hypotensive anesthesia, application of topical hemostatic agents to the decorticated bone, intra-operative cell salvage (ICS) system, acute normovolemic hemodilution, and administration of medications 2, 3, 10) .
Recently, the use of antifibrinolytics has become popular in major spinal surgeries. Tranexamic acid (TXA) is a synthetic antifibrinolytic amino acid derivative that forms a reversible complex with both plasminogen and plasmin by binding at lysine binding sites. This binding completely blocks the interaction of plasminogen and plasmin with lysine residues on the surface of fibrin, thereby preventing proteolytic action of plasmin on fibrin and inhibiting fibrinolysis at the surgical wound 7) . Although several literatures about TXA use demonstrated favorable results in spinal surgery, there still exists inconsistency.
The purpose of this study was to evaluate the effectiveness and safety of using TXA for spinal deformity surgery. This study also explored factors related to intra-operative surgical bleeding. The treatment regimen of TXA was a loading dose more than 15 minutes before skin incision, followed by a maintenance dose for the duration of the surgery. The dose of TXA was dichotomized by patient's age. In adult patients (≥18 years old), a regimen of a loading dose of 10 mg/kg, followed by a maintenance dose of 1 mg/kg/h was used. In pediatric population (<18 years old), a regimen of a loading dose of 50 mg/kg and maintenance dose of 5 mg/kg/h was utilized.
MATERIALS AND METHODS
The same blood transfusion guidelines were used for all patients. Allogeneic blood transfusion was performed if hemoglobin decreased to <7.0 mg/dL or if anemic symptoms developed, such as a decrease in blood pressure to <100 mmHg systolic, tachycardia greater than 100 beats/min, or a low urine output of <30 mL/h, even after initial fluid challenge with 500 mL normal saline in patients with a hemoglobin level between 7.0 and 8.0 mg/dL.
Statistical analysis
Using IBM SPSS 22.0 software for Windows (IBM Corp., Armonk, NY, USA), dichotomous data was compared using chi-square tests, whereas Student's t test were used for comparisons of parametric and nonparametric data, respectively.
A stepwise multiple regression analysis was performed between selected covariates to investigate the predictive factors of EBL. Statistical significance was set at p<0.05.
RESULTS
Descriptive analysis was performed to summarize patient and surgical characteristics. Eighty-nine (67.4%) patents were operated with administration of TXA, whereas forty-three (32.6%) patients without TXA (Table 1 ). There were no significant differences in terms of age, sex, BMI, diabetes, smoking status, preoperative hemoglobin, and previous surgery status between two groups. The proportion of patients with underlying hypertension was higher in TXA group than in non-TXA group (36.0 vs. 58.1%), and the difference was significant statistically (p=0.016). The proportion of patients taking anti-platelet medication was higher in non-TXA group (19.1 vs. 30.2%), however, the difference did not reach statistical significance (p=0.185).
Operative characteristics were summarized in Table 2 . The proportion of osteotomy was similar between TXA and non-TXA groups (39.3 vs. 37.2%). The differences were not significant either, regarding the number of fused segments and the number of interbody fusion in both groups. Surgical time had a trend toward shorter in TXA group than in non-TXA group (370.28 vs. 397.86 minutes), however the difference did not reach statistical significance (p=0.136).
Regarding surgical bleeding, TXA group was significantly 
Changes in hemoglobin level
In order to assess perioperative changes and differences in hemoglobin levels between the groups, analysis of variance was conducted. Routine hemoglobin levels were checked three times; preoperatively, postoperative day 1, and postoperative day 2 (Table 3) . In TXA group, preoperative hemoglobin level was slightly lower (12.97 vs. 13.03 g/dL), whereas slightly higher at postoperative day 1 (10.70 vs. 10.53 g/dL), and day 2 (10.36 vs. 10.18 g/dL). The differences were not significant between groups (p=0.762).
Predicting amount of surgical bleeding
To find out independent factors associated with surgical bleeding, multiple stepwise regression analysis was conducted upon variables, which showed statistically significance on correlation analysis of Pearson, including age, height, BMI, conduction of osteotomy, number of fused segments, number of interbody fusion, surgical time, and preoperative hemoglobin level. Use of TXA was negatively correlated with EBL (p=0.000), whereas surgical time was positively corre- 
Complications associated with TXA or allogeneic blood transfusions
Potential complications related to TXA or allogeneic blood transfusions were summarized in Table 5 . 
DISCUSSION
In the present study, we found the use of TXA was effective in reducing surgical bleeding, intra-operative transfusion requirements, and postoperative transfusion volume for patients undergoing spinal deformity surgeries. Also, there was a tendency toward lower postoperative transfusion rate and less postoperative drain amount in TXA group, although the differences did not reach statistical significance. These results were concordant with the majority of previous studies and recently published meta-analysis 5, 22, 23, 27) .
Plenty of studies demonstrated the efficacy of TXA use in reducing intra-operative blood loss in spinal surgeries. Previous researcher stated in their randomized prospective study that TXA use decreased surgical bleeding by 25% in adult patients having spinal fusion surgery 25) . Xie and colleagues also reported less surgical bleeding and transfusion amount in TXA group without increased rate of complications in spine correction surgery 26) . Moreover, another investigator notified less surgical time in TXA group in addition to the benefit of reduced surgical bleeding and transfusion amount 18) .
On the other hand, literatures reporting lack of efficacy of TXA use also exist. Previous investigator did not find any significant differences in intraoperative blood losses or transfusion requirements between TXA and control groups in patients with spinal deformity 17, 20) . Baldus and colleagues concluded in their study in patients undergoing lumbar pedicle subtraction osteotomy that TXA use did not decrease surgical bleeding or intraoperative transfusion amount whereas using aprotinin did 1) . These inconsistent results may warrant more number of future refined studies, despite most high level of evidence studies favor the use of TXA in spinal surgery 5, 24, 25) . Most studies showed tendency toward less postoperative bleeding in TXA group with or without statistical significance 1, 20, 24, 25) . Present study also demonstrated less postoperative drain amount in TXA group without reaching 23) . This less degree of impact on reducing postoperative bleeding of TXA compared to intraoperative bleeding could result in inconsistent statistical significances among studies.
There were no differences in hemoglobin levels between two groups. Previous studies reported inconsistent results regarding hematologic profiles. Some researchers found that postoperative hematocrit was significant higher in TXA group than control group 8, 25) . On the other hand, we found only statistically insignificant trend toward higher postoperative hemoglobin levels in TXA group, which was in accordance with the results described by Peters and colleagues 20) .
In this study, postoperative hemoglobin level was almost similar between groups in spite of larger blood loss in non-TXA group. This result may be attributed to larger transfused volume intraoperatively, by application of same blood transfusion guideline (described above) to maintain adequate intravascular volume.
Another issue with the use of TXA is about safety concerns. The primary concern with the use of TXA is the potential for an increased risk of thromboembolic complications such as peri-operative myocardial infarction, stroke, deep vein thrombosis, and pulmonary embolism 4, 25) . Also, there have been reports that use of high-dose TXA resulted in seizure in patients undergoing cardiac surgery 14, 16) . However, there has been no case reporting seizure associated with TXA use in patients having spine surgery, and recent literatures including meta-analysis demonstrated that TXA was not associated with increased incidence of such thromboembolic complications 5, 23) . The present study also showed that complication rate was not different between TXA group and control group.
The potential weakness of this study is that it was retrospective and non-randomized. When large amount of surgical bleeding was expected, however, it was reasonable to use TXA to avoid substantial blood loss and consequential serious complications. In fact, there were no significant differences in demographic data and surgical traits between two groups. The only difference was higher proportion of hypertension in non-TXA group, which might reflect higher incidence of past medical history of thromboembolic events that precluded the use of TXA. Furthermore, after adjusting potential bias and confounding variables, using TXA was still efficacious in decreasing intra-operative blood loss.
Another weakness was the heterogeneity of dose of TXA between adult and pediatric patients. TXA was administered to adult patients with lower dose, whereas pediatric patients with higher dose. It was because of the concerns about potential complications of thromboembolic events associated with TXA in older populations with higher comorbidities.
Despite studies reporting similar efficacy in reducing surgical bleeding and transfusion requirements in both low and high dose regimen 5) , unification of dosage would have drawn more refined results.
CONCLUSION
For spinal deformity surgery, use of TXA can provide beneficial effects not only on reducing surgical bleeding, but also on decreasing transfusion requirements both intra-and postoperatively. Incidence of thromboembolic event and other complications did not show any differences between TXA and non-TXA groups. Future prospective randomized study will be needed to ascertain the efficacy of routine use of TXA in major spinal surgery.
